Prognostic value and diagnostic performance of nectin-4-targeted [(68)Ga]Ga-FZ-NR-1 PET/CT versus [(18)F]FDG in recurrent or metastatic triple-negative breast cancer.

Li Y, Sun Y, Sun L, Wang D, Pan X, Xu X, Song S

Open source

DOI
10.1007/s00259-026-08177-7
Published
2026 Sep 12
Container
European journal of nuclear medicine and molecular imaging
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00259-026-08177-7,
  title = {Prognostic value and diagnostic performance of nectin-4-targeted [(68)Ga]Ga-FZ-NR-1 PET/CT versus [(18)F]FDG in recurrent or metastatic triple-negative breast cancer.},
  author = {Li Y and Sun Y and Sun L and Wang D and Pan X and Xu X and Song S},
  year = {2026},
  journal = {European journal of nuclear medicine and molecular imaging},
  doi = {10.1007/s00259-026-08177-7},
  url = {https://doi.org/10.1007/s00259-026-08177-7}
}

RIS

TY  - JOUR
TI  - Prognostic value and diagnostic performance of nectin-4-targeted [(68)Ga]Ga-FZ-NR-1 PET/CT versus [(18)F]FDG in recurrent or metastatic triple-negative breast cancer.
AU  - Li Y
AU  - Sun Y
AU  - Sun L
AU  - Wang D
AU  - Pan X
AU  - Xu X
AU  - Song S
PY  - 2026
JO  - European journal of nuclear medicine and molecular imaging
DO  - 10.1007/s00259-026-08177-7
UR  - https://doi.org/10.1007/s00259-026-08177-7
ER  - 

APA

Y, L., Y, S., L, S., D, W., X, P., X, X., & S, S. (2026). Prognostic value and diagnostic performance of nectin-4-targeted [(68)Ga]Ga-FZ-NR-1 PET/CT versus [(18)F]FDG in recurrent or metastatic triple-negative breast cancer.. European journal of nuclear medicine and molecular imaging. https://doi.org/10.1007/s00259-026-08177-7

Source records